Portuguese Health Minister Ana Paula Martins marked the 85th anniversary of the Liga Portuguesa Contra o Cancro (LPCC) on 13 April 2026 by praising the organisation as a unique bridge between the health system and citizens. She stressed the need to improve assessment tools, urging timely access to data from the National Cancer Registry to monitor disease trends, identify regional disparities, and evaluate treatment efficacy and investments. Martins advocated an integrated approach centred on patient dignity, highlighting the LPCC's role in prevention, health literacy, social and psychological support, and research, calling it an "unmissable reference of Portuguese society." Citing 2025 OECD data, she noted that Portugal's avoidable mortality rate is about 17% below the EU average, attributing this to the "extraordinary work" of health professionals and high-quality clinical care in reference hospitals and institutes. She identified structural challenges including strengthening care coordination, ensuring equitable access, and integrating non-clinical dimensions such as psychological support and combating patient isolation.
Prior coverage context Martins' remarks come amid broader EU efforts to improve cancer care and financial access for survivors. On World Cancer Day 2026, EU Commissioner Olivér Várhelyi proposed guidance to ensure fair financial access for cancer patients, building on the "right to be forgotten" enshrined in the 2023 Consumer Credit Directive, which prohibits insurers from using cancer history for credit-related insurance after a defined period. That provision enters into force in November 2026. Separately, the EU has invested in health system resilience abroad, completing a €50 million health programme in Jordan in April 2026 and launching a €15 million follow-up focused on primary care. Novartis also announced in April 2026 an expansion of community health programmes to over 30 countries by 2030, targeting heart disease and cancer in hard-to-reach communities.
Analytical core Martins' speech reveals a cleavage between improving patient dignity and data transparency versus the operational burden on health authorities. Positive impacts include better monitoring of cancer outcomes and reduced regional inequalities for patients, while negative impacts involve potential administrative costs for the National Cancer Registry to provide timely data. Key stakeholders affected are: cancer patients (positive: dignity-centred care, better data-driven treatment), the LPCC (positive: recognition and strengthened role), the Portuguese health system (negative: need to improve data sharing and coordination), and the insurance sector (indirectly affected by EU-level right-to-be-forgotten rules).
← Atlas › News › Health & Lifestyle